FR2029415A1 - 2-chloro-6alpha 9alpha-difluoro-16alpha-methylpregna-1 - Google Patents

2-chloro-6alpha 9alpha-difluoro-16alpha-methylpregna-1

Info

Publication number
FR2029415A1
FR2029415A1 FR6901893A FR6901893A FR2029415A1 FR 2029415 A1 FR2029415 A1 FR 2029415A1 FR 6901893 A FR6901893 A FR 6901893A FR 6901893 A FR6901893 A FR 6901893A FR 2029415 A1 FR2029415 A1 FR 2029415A1
Authority
FR
France
Prior art keywords
activity
thymolytic
9alpha
6alpha
16alpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR6901893A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Priority to FR6901893A priority Critical patent/FR2029415A1/en
Publication of FR2029415A1 publication Critical patent/FR2029415A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Cpds. of formula (I) R' = OH opt. esterified or etherified Y = H, OH opt. esterified. Thymolytic, suprarenal inhibitory and anti-inflammatory activity. 0.3-3 mg/kg. orally or 1-10 mg/kg. s.c. in rats markedly inhibits foreign-body-induced granuloma. The thymolytic effect is 10 times greater than the anti-inflammatory effect when a 21-acetate is admin. orally. The 21-pivalate corresponding to the 21-acetate has a similar anti-inflammatory activity but the thymolytic activity is less than the anti-inflamm. activity. May be used in animal foods.
FR6901893A 1969-01-30 1969-01-30 2-chloro-6alpha 9alpha-difluoro-16alpha-methylpregna-1 Withdrawn FR2029415A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR6901893A FR2029415A1 (en) 1969-01-30 1969-01-30 2-chloro-6alpha 9alpha-difluoro-16alpha-methylpregna-1

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR6901893A FR2029415A1 (en) 1969-01-30 1969-01-30 2-chloro-6alpha 9alpha-difluoro-16alpha-methylpregna-1

Publications (1)

Publication Number Publication Date
FR2029415A1 true FR2029415A1 (en) 1970-10-23

Family

ID=9028374

Family Applications (1)

Application Number Title Priority Date Filing Date
FR6901893A Withdrawn FR2029415A1 (en) 1969-01-30 1969-01-30 2-chloro-6alpha 9alpha-difluoro-16alpha-methylpregna-1

Country Status (1)

Country Link
FR (1) FR2029415A1 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3152154A (en) * 1961-06-24 1964-10-06 Vismara Francesco Spa 17-monoesters of 17alpha, 21-dihydroxy steroids and process for the preparation thereof
US3232835A (en) * 1957-12-04 1966-02-01 Pfizer & Co C 2-chloro prednisones and the 9alpha-fluoro derivatives thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3232835A (en) * 1957-12-04 1966-02-01 Pfizer & Co C 2-chloro prednisones and the 9alpha-fluoro derivatives thereof
US3152154A (en) * 1961-06-24 1964-10-06 Vismara Francesco Spa 17-monoesters of 17alpha, 21-dihydroxy steroids and process for the preparation thereof

Similar Documents

Publication Publication Date Title
NL6902213A (en) 2-chloro-6alpha 9alpha-difluoro-16alpha-methylpregna-1
FR2029415A1 (en) 2-chloro-6alpha 9alpha-difluoro-16alpha-methylpregna-1
CA960689A (en) 2-naphthyl acetic acid derivatives and compositions
CA1001074A (en) Glucocorticoid-like water diuretic and anti-inflammatory compositions
CA767696A (en) Purification of terephthalic acid and/or benzophenone 4,4'-dicarboxylic acid
FR2081580A1 (en) Pharmacol-active 2,4,6-trimethoxybenzoates
AU466039B2 (en) Glucocorticoid-like water diuretic and antiinflammatory compositions
CA597928A (en) Normorphine and norcodeine derivatives
CA991655A (en) 2-naphthyl acetic acid derivatives and compositions
CA592045A (en) Pharmaceutically effective water insoluble derivatives of ephedrine and propadrine
CA619203A (en) Prevention of deposition of pitch in papermaking
CA742211A (en) 7.alpha.-METHYL ESTRONE AND DERIVATIVES
AU250409B2 (en) Improvements in or relating to derivatives of furaltadone
AU4652068A (en) Improvements in or relating to the treatment of hypertension
CA1013611A (en) Prevention of pecting related diseases in ruminants
CA983025A (en) 6-isocyanatopenicillanic acid derivatives and pencillins
CA807126A (en) Anti-inflammatory compositions comprising 4-quinazolone and 4-pyrimidone derivatives
AU252720B2 (en) Improvements in or relating to the treatment of cellulose film
CA610350A (en) Esters of 14,17,21-trihydroxy-4-pregnene-3,20-dione
AU428346B2 (en) Process forthe preparation of 7 aminocephal osporanic acid and its derivatives
AU559261A (en) Improvements in or relating to derivatives of furaltadone
AU240288B2 (en) Improvements in or relating to sanitary napkins
AU252214B2 (en) 16,17 - acetal and ketal derivatives of 6 b - hlo-16,17 - dihydroxy progesterones and the process for their preparation
GB1115703A (en) Pharmaceutical anti-androgenic composition and dosage units thereof
AU254805B2 (en) 3, 20-diketals of 17- hydroxy-16 -methyl-pregn 5-ene-3, 20-dione, their preparation and conversion to other steriods

Legal Events

Date Code Title Description
CD Change of name or company name
ST Notification of lapse